Delivery Order SPE2DB20D2104-SPE2DB25FMHLN

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.48 firm fixed-price delivery order contract is for the supply of JANUMET 50-1,000 MG TABLET 60S, a medication used to treat diabetes. The contract has an ultimate completion date of June 26, 2024 and was awarded on June 25, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,878.18 firm-fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to manage diabetes. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award, valued at $5,600.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 31, 2025. This award is associated with Amerisourcebergen's larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract, valued at $1,735.62, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. This is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999...
This federal contract award, valued at $3,009.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price Delivery Order. This contract award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award, worth $22,582.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of JANUMET 50-1,000 MG TABLET 180S, a prescription medication. The contract has an ultimate completion date of January 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,478.15 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $17,044.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of JANUMET 50-1,000 MG TABLET 180S, a prescription medication. The contract has an ultimate completion date of December 17, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,086.66 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,964.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication, with a performance period ending on March 3, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMHLN
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide JANUMET 50-1,000 MG TABLET 180S, a diabetes medication. The contract is a delivery order valued at $4,031.92 with a firm fixed price and has an ultimate completion date of February 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition.

Generated 5/21/25, 9:55 AM